The Effect of Different Ketone Supplements on β-OHB and Blood Glucose in Healthy Individuals
NCT ID: NCT05273411
Last Updated: 2024-08-01
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
12 participants
INTERVENTIONAL
2022-03-24
2022-05-18
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Metabolomic Signature of Exogenous Ketosis
NCT05699707
The Effects of Exogenous Ketones on Glucose Tolerance
NCT04088617
Exogenous Ketones and Glucose Tolerance
NCT03461068
Effects of Exogenous Ketones in Healthy Young Adults
NCT03452761
Acceptability and Tolerability of Ketone Supplements and Effects of BHB Concentrations in Young Adults
NCT05390385
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
OTHER
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
(R)-3-hydroxybutyl (R)-3-hydroxybutyrate ketone monoester
1 x 20 mL
(R)-3-hydroxybutyl (R)-3-hydroxybutyrate ketone monoester
Single-dose pharmacokinetic study over 4 hours.
Beta-hydroxybutyric acid
1 x 237 mL
Beta-hydroxybutyric acid
Beta-hydroxybutyric acid
1,3-Butanediol
1 x 35 mL
1,3-Butanediol
1,3-Butanediol
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
(R)-3-hydroxybutyl (R)-3-hydroxybutyrate ketone monoester
Single-dose pharmacokinetic study over 4 hours.
Beta-hydroxybutyric acid
Beta-hydroxybutyric acid
1,3-Butanediol
1,3-Butanediol
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* able to fast overnight
Exclusion Criteria
* following a ketogenic diet, low-calorie diet, periodic fasting regimen, or regularly consuming ketogenic supplements;
* being unable to travel to and from the university;
* being unable to follow the diet instructions;
* being pregnant or planning to become pregnant during the study;
* having been diagnosed with a chronic disorder of glucose or fat metabolism, including type 2 diabetes, chronic pancreatitis, or gallbladder disease;
* being unable to read or communicate in English
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of British Columbia
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jonathan Little
Dr. Jonathan Little, Associate Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of British Columbia Okanagan
Kelowna, British Columbia, Canada
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
H22-00083
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.